BioCardia (BCDA) Short Interest Ratio & Short Volume $3.14 +0.09 (+2.95%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioCardia Short Interest DataBioCardia (BCDA) has a short interest of 39,900 shares, representing 1.08% of the float (the number of shares available for trading by the public). This marks a -24.43% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 283,754 shares to cover all short positions.Current Short Interest39,900 sharesPrevious Short Interest52,800 sharesChange Vs. Previous Month-24.43%Dollar Volume Sold Short$81,795.00Short Interest Ratio0.6 Days to CoverLast Record DateApril 15, 2025Outstanding Shares4,680,000 sharesFloat Size3,690,000 sharesShort Percent of Float1.08%Today's Trading Volume158,813 sharesAverage Trading Volume283,754 sharesToday's Volume Vs. Average56% Short Selling BioCardia? Sign up to receive the latest short interest report for BioCardia and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCDA Short Interest Over TimeBCDA Days to Cover Over TimeBCDA Percentage of Float Shorted Over Time BioCardia Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202539,900 shares $81,795.00 -24.4%1.1%0.6 $2.05 3/31/202552,800 shares $134,112.00 +5.6%1.4%0.8 $2.54 3/15/202550,000 shares $130,000.00 +111.0%1.4%1 $2.60 2/28/202523,700 shares $47,637.00 -57.8%0.7%0.5 $2.01 2/15/202556,200 shares $159,608.00 +4.7%1.5%1.2 $2.84 1/31/202553,700 shares $132,639.00 +67.3%1.4%1.1 $2.47 1/15/202532,100 shares $71,262.00 -36.3%0.8%0.6 $2.22 12/31/202450,400 shares $109,872.00 -39.6%1.3%1 $2.18 12/15/202483,400 shares $173,472.00 -19.5%2.2%1.5 $2.08 11/30/2024103,600 shares $236,208.00 -5.4%2.9%1 $2.28 Get the Latest News and Ratings for BCDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioCardia and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024109,500 shares $202,575.00 +26.9%3.1%0.1 $1.85 10/31/202486,300 shares $201,079.00 +72.6%3.2%0.1 $2.33 10/15/202450,000 shares $122,000.00 -62.2%1.8%0.1 $2.44 9/30/2024132,100 shares $412,152.00 -12.6%4.8%0.2 $3.12 9/15/2024151,200 shares $449,064.00 -91.7%6.4%0.2 $2.97 8/31/20241,830,000 shares $5.58 million +2,719.7%84.3%2.3 $3.05 8/15/202464,900 shares $188,210.00 +104.1%4.3%0.4 $2.90 7/31/202431,800 shares $95,718.00 +8.2%2.5%0.2 $3.01 7/15/202429,400 shares $104,076.00 -38.8%2.3%0.2 $3.54 6/30/202448,000 shares $142,560.00 -37.7%3.7%0.4 $2.97 6/15/202477,100 shares $262,911.00 +267.1%6.0%0.6 $3.41 5/31/202421,000 shares $97,020.00 -91.1%1.6%0.2 $4.62 5/15/2024235,400 shares $92,041.40 -10.4%N/A0.7 $0.39 4/30/2024262,800 shares $101,729.88 -3.1%N/A0.8 $0.39 4/15/2024271,200 shares $100,994.88 -49.4%N/A0.8 $0.37 3/31/2024535,900 shares $218,111.30 -46.9%N/A1.4 $0.41 3/15/20241,010,000 shares $393,900.00 +927.5%6.2%2.7 $0.39 2/29/202498,300 shares $54,065.00 -67.0%0.7%0.3 $0.55 2/15/2024297,600 shares $127,968.00 +84.2%2.5%1 $0.43 1/31/2024161,600 shares $73,237.12 +22.8%1.3%0.1 $0.45 1/15/2024131,600 shares $85,329.44 -39.2%1.1%0 $0.65 12/31/2023216,600 shares $143,865.72 -31.8%1.8%0.1 $0.66 12/15/2023317,800 shares $190,997.80 -9.0%2.7%0.1 $0.60 11/30/2023349,100 shares $216,860.92 +132.0%3.5%0.1 $0.62 11/15/2023150,500 shares $142,222.50 +13.4%1.5%0.1 $0.95 10/31/2023132,700 shares $49,404.21 -35.2%1.3%1.2 $0.37 10/15/2023204,900 shares $90,156.00 +9.8%2.1%1.5 $0.44 9/30/2023186,600 shares $80,219.34 +48.1%1.6%1.4 $0.43 9/15/2023126,000 shares $49,770.00 -36.7%1.1%0.9 $0.40 8/31/2023199,000 shares $155,220.00 +8.0%1.7%1.8 $0.78Trump announcement boosts “next Bitcoin” (Ad)President Trump just made his first big crypto move ... Announcing the creation of a national strategic reserve for Bitcoin and Ethereum. But there's something else going on here …To learn more about this next Bitcoin — click here before another proclamation by Trump sends the pr 8/15/2023184,300 shares $162,147.14 +575.1%1.5%1.9 $0.88 7/31/202327,300 shares $28,119.00 -84.0%0.2%0.3 $1.03 7/15/2023171,000 shares $398,430.00 -14.2%1.4%2.4 $2.33 6/30/2023199,400 shares $532,398.00 -4.3%1.6%5.1 $2.67 6/15/2023208,300 shares $477,007.00 +3.8%1.6%5.6 $2.29 5/31/2023200,600 shares $355,062.00 +1,443.1%1.6%6.9 $1.77 5/15/202313,000 shares $24,050.00 -29.4%0.1%0.5 $1.85 4/30/202318,400 shares $37,904.00 -12.0%0.1%0.9 $2.06 4/15/202320,900 shares $40,964.00 -23.7%0.1%0.9 $1.96 3/31/202327,400 shares $53,430.00 -26.9%0.2%1 $1.95 3/15/202337,500 shares $73,875.00 +4.8%0.3%1.2 $1.97 2/28/202335,800 shares $78,760.00 +96.7%0.3%0.7 $2.20 2/15/202318,200 shares $40,586.00 -56.6%0.1%0.4 $2.23 1/31/202341,900 shares $106,426.00 -4.3%0.3%0.9 $2.54 1/15/202343,800 shares $100,302.00 -15.4%0.4%1 $2.29 12/30/202251,800 shares $108,262.00 -40.6%0.4%1.2 $2.09 12/15/202287,200 shares $149,112.00 +149.1%0.7%2 $1.71 11/30/202235,000 shares $64,750.00 +44.0%0.2%0.8 $1.85 11/15/202224,300 shares $45,684.00 -42.1%0.2%0.5 $1.88 10/31/202242,000 shares $81,900.00 -24.5%0.3%0.7 $1.95 10/15/202255,600 shares $116,204.00 -37.3%0.4%0.9 $2.09 9/30/202288,600 shares $171,884.00 -7.2%0.7%1.4 $1.94 9/15/202295,500 shares $193,865.00 -2.7%0.7%1.6 $2.03 8/31/202298,100 shares $195,219.00 +182.7%0.7%1.4 $1.99 8/15/202234,700 shares $58,296.00 -42.1%0.3%0.7 $1.68 7/31/202259,900 shares $86,855.00 -25.7%0.5%1.2 $1.45 7/15/202280,600 shares $124,930.00 -47.7%0.8%1.2 $1.55 6/30/2022154,200 shares $223,590.00 -29.3%1.6%0.2 $1.45 6/15/2022218,100 shares $307,521.00 -42.2%2.3%0.3 $1.41 5/31/2022377,300 shares $633,864.00 -2.8%2.9%0.6 $1.68 5/15/2022388,200 shares $543,480.00 -38.1%3.0%0.6 $1.40 4/30/2022627,000 shares $965,580.00 -49.8%5.0%0.7 $1.54 4/15/20221,250,000 shares $1.86 million +150.1%10.0%0.7 $1.49 3/31/2022499,900 shares $1.03 million -5.7%4.0%0.4 $2.07 3/15/2022530,100 shares $1.03 million -10.4%4.2%0.4 $1.95 2/28/2022591,700 shares $1.22 million -45.2%4.7%0.4 $2.07 2/15/20221,080,000 shares $2.39 million +425.3%8.5%0.8 $2.21 1/31/2022205,600 shares $380,360.00 -7.3%1.6%0.2 $1.85 1/15/2022221,700 shares $390,192.00 -13.8%1.7%1.5 $1.76 12/31/2021257,300 shares $499,162.00 +57.5%2.0%1.8 $1.94 12/15/2021163,400 shares $281,048.00 -30.9%1.3%1.2 $1.72 11/30/2021236,300 shares $484,415.00 -10.0%1.9%1.7 $2.05 11/15/2021262,600 shares $643,370.00 -10.5%2.1%1.9 $2.45 10/29/2021293,300 shares $821,240.00 +3.8%2.3%2.1 $2.80 10/15/2021282,700 shares $828,311.00 +8.7%2.2%2 $2.93 9/30/2021260,000 shares $816,400.00 +33.2%2.0%1.8 $3.14 9/15/2021195,200 shares $554,368.00 -0.9%1.5%1.4 $2.84 8/31/2021197,000 shares $581,150.00 -34.0%1.6%2.8 $2.95 8/13/2021298,300 shares $924,730.00 +5.3%2.3%4 $3.10 7/30/2021283,400 shares $940,888.00 -13.8%2.2%3.8 $3.32Trump announcement boosts “next Bitcoin” (Ad)President Trump just made his first big crypto move ... Announcing the creation of a national strategic reserve for Bitcoin and Ethereum. But there's something else going on here …To learn more about this next Bitcoin — click here before another proclamation by Trump sends the pr 7/15/2021328,900 shares $1.11 million -10.7%2.6%4.2 $3.36 6/30/2021368,200 shares $1.46 million +2.1%2.9%4.2 $3.97 6/15/2021360,500 shares $1.60 million -20.0%2.8%3.4 $4.43 5/28/2021450,400 shares $1.84 million +4.9%3.6%4.3 $4.09 5/14/2021429,300 shares $1.43 million +2.0%N/A3.6 $3.32 4/30/2021420,900 shares $1.49 million -0.2%N/A2.6 $3.54 4/15/2021421,900 shares $1.73 million -7.9%N/A1.8 $4.09 3/31/2021458,300 shares $1.82 million +68.4%N/A1.5 $3.98 3/15/2021272,200 shares $1.09 million +25.3%N/A0.5 $4.00 2/26/2021217,300 shares $873,546.00 +0.5%N/A0.1 $4.02 2/12/2021216,200 shares $1.08 million -63.5%N/A0.1 $4.98 1/29/2021591,600 shares $2.48 million -33.8%N/A0.2 $4.20 1/15/2021894,200 shares $3.35 million +49.8%N/A0.2 $3.75 12/31/2020597,100 shares $2.10 million +4,715.3%N/A0.2 $3.52 12/15/202012,400 shares $55,552.00 +9.7%N/A0 $4.48 11/30/202011,300 shares $26,555.00 -6.6%N/A0.2 $2.35 11/15/202012,100 shares $26,257.00 -57.4%N/A0.2 $2.17 10/30/202028,400 shares $58,220.00 +3.7%N/A0.3 $2.05 10/15/202027,400 shares $64,664.00 -9.9%N/A0.3 $2.36 9/30/202030,400 shares $69,008.00 +237.8%N/A0.3 $2.27 9/15/20209,000 shares $21,375.00 -61.9%N/A0 $2.38 BCDA Short Interest - Frequently Asked Questions What is BioCardia's current short interest? Short interest is the volume of BioCardia shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 39,900 shares of BCDA short. 1.08% of BioCardia's shares are currently sold short. Learn More on BioCardia's current short interest. What is a good short interest ratio for BioCardia? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCDA shares currently have a short interest ratio of 1.0. Learn More on BioCardia's short interest ratio. Which institutional investors are shorting BioCardia? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioCardia: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for BioCardia? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.08% of BioCardia's floating shares are currently sold short. Is BioCardia's short interest increasing or decreasing? BioCardia saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 39,900 shares, a decrease of 24.4% from the previous total of 52,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioCardia's float size? BioCardia currently has issued a total of 4,680,000 shares. Some of BioCardia's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioCardia currently has a public float of 3,690,000 shares. How does BioCardia's short interest compare to its competitors? 1.08% of BioCardia's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioCardia: NRx Pharmaceuticals, Inc. (8.84%), Surrozen, Inc. (4.90%), Alterity Therapeutics Limited (0.39%), Cadrenal Therapeutics, Inc. (2.45%), Pluri Inc. (0.24%), Marinus Pharmaceuticals, Inc. (3.95%), Kezar Life Sciences, Inc. (1.09%), ALX Oncology Holdings Inc. (18.06%), Estrella Immunopharma, Inc. (0.02%), Allakos Inc. (1.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short BioCardia stock? Short selling BCDA is an investing strategy that aims to generate trading profit from BioCardia as its price is falling. BCDA shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioCardia? A short squeeze for BioCardia occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCDA, which in turn drives the price of the stock up even further. How often is BioCardia's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCDA, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies NRx Pharmaceuticals Short Interest Surrozen Short Interest Alterity Therapeutics Short Interest Cadrenal Therapeutics Short Interest Pluri Short Interest Marinus Pharmaceuticals Short Interest Kezar Life Sciences Short Interest ALX Oncology Short Interest Estrella Immunopharma Short Interest Allakos Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCDA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCDA Stock Free BCDA Stock Alerts